Beijing Succeeder Technology Inc.
- Jurisdiction
China - ISIN
CNE1000044C4 (688338.SS )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
6
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
4
/ 7
Profile
Beijing Succeeder Technology Inc. engages in the research and development, manufacture, and sale of in-vitro diagnostic products in China and internationally. Read full profile
Fundamentals
- Net revenue
€35.44M - Gross margin
60.1% - EBIT
€13.63M - EBIT margin
38.4% - Net income
€12.58M - Net margin
35.5%
Statement period: - (published )
Stock price
Dividends
- Last dividend amount
-
CN¥0.33 - Ex date
-
- Payment date
-
- Dividend payout ratio
-
-0.0%
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions